Search Medical Condition
Please enter condition
Please choose location from dropdown

South Miami, Florida Clinical Trials

A listing of South Miami, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (1198) clinical trials

Placebo Controlled Multiple Ascending Dose Study to Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics of SAP-001 in Gout Patients

This multiple ascending dose trial will include up to 4 cohorts. Each cohort will be comprised of 15 patients who will be dosed with SAP-001 or placebo once daily (QD) for 28 days. Dose escalation from Cohort 1 to Cohort 2 and from Cohort 2 to Cohort 3 will occur ...

Phase

0.48 miles

Learn More »

A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

The purpose of the study is the measure the levels of lasmiditan in the body of children aged 6 to 17 with migraine. The study also will also examine the safety and tolerability of lasmiditan in children aged 6 to 17 with migraine. The study will last about 6 weeks, ...

Phase

0.48 miles

Learn More »

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

The purpose of this study is to evaluate the safety and reactogenicity of three doses of VAC52416 (ExPEC10V) and to evaluate the dosedependent immunogenicity of ExPEC10V as measured by enzyme-linked immunosorbent assay (ELISA) and opsonophagocytic killing assay (OPA) on Day 15 in participants greater than equal to 60 to less ...

Phase

0.48 miles

Learn More »

The purpose of this clinical study is to see how safe and well EpiCord Dehydrated Human Umbilical Cord Allograft plus moist wound therapy and offloading, meaning reduced-weight bearing (Standard of Care) works versus Standard of Care alone in the treatment of diabetic foot ulcers. The purpose of this clinical study ...

Phase N/A

0.48 miles

Learn More »

The purpose of this research study is to find out if a drug called efinaconazole 10% is safe for children to use when treating toenail fungus (also known as onychomycosis). In addition, this study will measure how much of the study drug gets into the blood stream and how long ...

Phase N/A

0.48 miles

Learn More »

The purpose of this study is to examine the effects of the ACTitouch® Adaptive Compression in healing venous leg ulcers compared to multi-layer bandaging wraps such as PROFORE and Coban™ 2. The ACTitouch device has been cleared by the Food and Drug Administration (FDA) and is available with a prescription ...

Phase N/A

0.48 miles

Learn More »

This study is a multi-center, randomized, double blind, placebo-controlled dose-response study designed to evaluate VF-001-DP as an adjunct to SC, versus Placebo and SC in the treatment of chronic VLUs. The SC therapy for VLUs is a moisture retentive ulcer dressing and multi-layer compression therapy. Mepitel® and Coban2® have been ...

Phase

0.48 miles

Learn More »

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

This is a randomized, double-blind, placebo-controlled study to assess the safety and tolerability of GRF6021, a plasma derived product, administered by intravenous (IV) infusion to subjects with Parkinson's disease (PD) and cognitive impairment. The study duration for the subjects will be approximately 7 months.

Phase

0.48 miles

Learn More »

A Study Evaluating the Safety Tolerability and Efficacy of Two Injections of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

The primary purpose of this phase 2, placebo-controlled, double-blind, parallel group study is to provide an initial evaluation of two intra-articular (IA) injections of SM04690 (each at the dose of 0.07mg per 2mL injection) approximately six months apart into the target knee of moderately to severely symptomatic osteoarthritis (OA) subjects. ...

Phase

0.48 miles

Learn More »

Multiple Ascending Dose Study of AMG 598 in Subjects With Obesity

This is a randomized, double-blind, placebo-controlled, multiple ascending dose study in subjects with obesity. AMG 598 will be evaluated in approximately 108 subjects to assess safety, tolerability, pharmacokinetics and pharmacodynamic effects.

Phase

0.48 miles

Learn More »